Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Dec 22, 2023 1:05pm
48 Views
Post# 35798016

RE:RE:End of year share price

RE:RE:End of year share priceIn terms of real value CZO could arguably be seen as worth $1.25 right now.

What's the value of AEZS's C$50 million cash, C$113 million in tax loss carryforwards, a diagnostic cashcow about to be partnered with its most important market potentially approved in 2024, and pipeline of other assets(eg. AIM Biologicals)?

That should be worth at least C$100 million, in my opinion. AEZS wouldn't agree to a merger of equals if it didn't see CZO's real value at about C$100 million. A C$100 million value with 80 million CZO shares is $1.25 per share. If the deal is completed and the expected diagnostic test deal and PGX deal are announced that value could be realized; exspecially if the biotech market has legs. The company also has a number of other events ahead.   

Apostata wrote: Here's a blast from the past. Anyone remember August?
Apostata wrote: Since we're all stuck here in limbo, I thought I'd see whether anyone would like to guess where the share price will be at the end of the last trading day of 2023. 

I'm going to say .54

Any takers?

This company has become a joke.


<< Previous
Bullboard Posts
Next >>